Penn cell therapy pioneer Dr. Carl June wins $1M prize
Cell therapy pioneer Dr. Carl June was named the recipient of this year’s $1 million Sanford Lorraine Cross Award for his groundbreaking work in developing chimeric antigen receptor (CAR) T cell therapy.
The biennial award, given by Sioux Falls, South Dakota-based Sanford Health, recognizes “life-changing breakthroughs” and bringing emerging transformative medical innovations to patients. Sanford Health is the only health system in the country to award a $1 million prize for achievements in the medical sciences.
June is the director of the Center for Cellular Immunotherapies at the University of Pennsylvania’s Abramson Cancer Center. He is also a professor of immunology in the department of pathology and laboratory medicine at Penn’s Perelman School of Medicine.
“This is a well-deserved and exciting award for one of Penn’s most distinguished faculty members, whose pioneering research has reshaped the fight against cancer and brought fresh hope for both adults and children with the disease,” said Dr. J. Larry Jameson, Penn’s executive vice president for its health system and dean of the Perelman School of Medicine. “His contributions truly have been transformative for patients across the globe and taken the field of oncology in new and powerful directions.”
Click here to read more via The Philly Biz Journal.
Latest posts by BioBuzz Media (see all)
- Matan Signs Deal with Ellume for Two Full Buildings at Progress Labs at Center 85 - May 11, 2021
- Adaptive Phage Therapeutics Announces $40.75 Million Series B Financing - May 11, 2021
- Gaithersburg’s Novavax Announces Positive Preclinical Data for Combination Influenza and COVID-19 Vaccine Candidate - May 10, 2021
- Global Biotech Company, Ellume, to Open Manufacturing Facility in Frederick - May 10, 2021
- Maryland Stem Cell Research Commission Announces over $6 Million in Awards to Accelerate Cures - May 10, 2021